TFAP2B binds to the promoter of COX-2 to activate its expression, revealing that TFAP2B is a ponderable regulatory molecule in the COX-2 signaling pathway, affecting tumor progression in thyroid cancer and is a potentially effective target for thyroid cancer diagnosis and therapy. Here, PTGS2 is linked to thyroid gland carcinoma.